Download Files:
Tibenelast sodium
SKU
HY-101705-10 mg
Category Reference compound
Tags Inflammation/Immunology, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
$180 – $1,750
Products Details
Product Description
– Tibenelast sodium is a phosphodiesterase inhibitor.
Web ID
– HY-101705
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C13H13NaO4S
References
– [1]Schwertschlag US, et al. Effect of tibenelast (a phosphodiesterase inhibitor) and theophylline on isoproterenol-stimulated heart rate, cyclic AMP and norepinephrine levels. Pharmacology. 1993;46(3):142-7.|[2]Ho PP, et al. Tibenelast, 5,6-diethoxybenzo(B)thiophene-2-carboxylic acid, sodium salt (LY186655), is an orally active anti-asthma compound in the guinea pig. Life Sci. 1990;46(13):917-25.
CAS Number
– 105102-18-9
Molecular Weight
– 288.29
Compound Purity
– 99.64
SMILES
– O=C(C1=CC2=CC(OCC)=C(OCC)C=C2S1)[O-].[Na+]
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.